Talk:Nirmatrelvir/ritonavir

This is the talk page for discussing improvements to the Nirmatrelvir/ritonavir article. This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic. New to Wikipedia? Welcome! Learn to edit; get help. Assume good faith Be polite and avoid personal attacks Be welcoming to newcomers Seek dispute resolution if needed Article policies Neutral point of view No original research Verifiability

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Archives: 1Auto-archiving period: 1 year

The contentious topics procedure applies to this page. This page is related to COVID-19, broadly construed, which has been designated as a contentious topic. Editors who repeatedly or seriously fail to adhere to the purpose of Wikipedia, any expected standards of behaviour, or any normal editorial process may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the contentious topics procedures before editing this page.

This article is rated C-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects:

Pharmacology High‑importance This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles High This article has been rated as High-importance on the project's importance scale. Medicine Mid‑importance This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles Mid This article has been rated as Mid-importance on the project's importance scale. chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles Low This article has been rated as Low-importance on the project's importance scale.

Skepticism Low‑importance

This article is within the scope of WikiProject Skepticism, a collaborative effort to improve the coverage of science, pseudoscience, pseudohistory and skepticism related articles on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.SkepticismWikipedia:WikiProject SkepticismTemplate:WikiProject SkepticismSkepticism articles Low This article has been rated as Low-importance on the project's importance scale.

	COVID-19 High‑importance
This article is within the scope of WikiProject COVID-19, a project to coordinate efforts to improve all COVID-19-related articles. If you would like to help, you are invited to join and to participate in project discussions.COVID-19Wikipedia:WikiProject COVID-19Template:WikiProject COVID-19COVID-19 articles High This article has been rated as High-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Nirmatrelvir/ritonavir. PubMed provides review articles from the past five years (limit to free review articles) The TRIP database provides clinical publications about evidence-based medicine. Other potential sources include: Centre for Reviews and Dissemination and CDC

Text and/or other creative content from this version of Nirmatrelvir was copied or moved into Nirmatrelvir/ritonavir with this edit. The former page's history now serves to provide attribution for that content in the latter page, and it must not be deleted as long as the latter page exists.

It's not quite clear the relevance of the final line in the 'Economics' section, parts of which are lifted close-to-verbatim from the FT article it cites.

While somewhat informative, the article also only demonstrates two cases of Paxlovid being given as a gift. Further, the language in the sentence is very similar to that in the FT article, and it seems not much effort has been made to de-editorialize it, so to speak. So, first I would question the relevance of the sentence altogether. The FT article cited doesn't demonstrate the extent of the phenomena well enough to warrant inclusion in this article. Second, at minimum the language should be changed to be more neutral and fitting for an encyclopedia. Since the article is unlocked, I'm going to use my discretion and delete. Evan.morien (talk) 11:13, 5 December 2023 (UTC)[reply]

It might be helpful to include that; the Pfizer commercial has actors saying "If it's COVID, it's Paxlovid", but that's obviously a primary source so I'm assuming it's a no-go. Mapsax (talk) 01:31, 17 January 2024 (UTC)[reply]

Lede contains as of today 2 paragraphs about regulatory history (!) but nothing about the medically important rebound phenomenon, as present in the body of the page. Lede was stuffed with recentism and is cluttered with refs. Wikipedia:Manual of Style/Lead section. Wuerzele (talk) 09:42, 25 February 2024 (UTC)[reply]